Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Mar;38(3):e247-e249.
doi: 10.1111/jdv.19553. Epub 2023 Oct 16.

Ponatinib-induced desquamation-Unifying eponymous terminology for a rare adverse event

Mohammad Danish  1 , Varniraj Patel  1 , Sudheer Arava  2 , Rhea Ahuja  1
Affiliations
Case Reports

Ponatinib-induced desquamation-Unifying eponymous terminology for a rare adverse event

Mohammad Danish et al. J Eur Acad Dermatol Venereol. 2024 Mar.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Hoy SM. Ponatinib: a review of its use in adults with chronic myeloid Leukaemia or Philadelphia chromosome-positive acute lymphoblastic Leukaemia. Drugs. 2014;74:793-806.
    1. Ransohoff JD, Kwong BY. Cutaneous adverse events of targeted therapies for hematolymphoid malignancies. Clin Lymphoma Myeloma Leuk. 2017;17(12):834-851.
    1. Karim MS, Watson I, Boh EE. Diffuse plate-like sheets of desquamation. JAAD Case Rep. 2022;21:52-55.
    1. Fernández-González P, Buendía-Castaño D, Saceda-Corralo D, Jaen-Olasolo P. Ichthyosiform reaction related to ponatinib therapy. Actas Dermosifiliogr. 2019;110(10):873-875.
    1. Thakur V, Malhotra P, Lad D, Chatterjee D, Vinay K, Dogra S. Ponatinib-induced lamellar ichthyosis-like eruption. Int J Dermatol. 2020;59(5):e156-e157.

LinkOut - more resources